News and Updates

Henry Waxman Debunks Pharmaceutical Industry Claims of Innovation Loss, Again

In a blog post for Health Affairs, Chairman Henry Waxman  debunks the age-old industry claim that lower drug costs mean a loss of drug innovation, noting they made the same unsubstantiated claim back in the 1980s during debate on the Hatch-Waxman Act.

Henry Waxman Discusses The Lower Drug Costs Now Act in Health Affairs

In a piece written for Health Affairs this week, our Chairman Henry Waxman discusses the broken pharmaceutical marketplace, how empowering Medicare to negotiate prices with the pharmaceutical industry will make prescription drugs more affordable for everyone, and why we need the Lower Drug Costs Now Act.

Waxman Strategies in Health Affairs

In a piece written for Health Affairs this week, Health Practice Managing Director Kristi Martin joins Jonathan Foley of Westcott Partners and Rob Shriver of IdeaCrew to discuss the Affordable Care Act’s Multi-State Plan Program, lessons learned from its demise and how we can use those lessons to inform discussion on the public option.

Cocktails & Climate Week: Waxman Strategies Goes to NYC

This week, many of us here at Waxman Strategies packed our bags and temporarily relocated to New York City, where we were thrilled to host a reception as an official part of Climate Week NYC. The event, an evening of cocktails, hors d’oeuvres, and conversation, was held at Candle 79, an upscale restaurant with a plant-based menu.

Best New Office Space in DC – Yes, We’ve Got it

Selecting and designing an office space is no easy feat. There’s a whole lot to consider, starting with how we create an environment that reinforces who we are and reflects our culture and values. Well, our new space is done and we think we’ve nailed it.

Support for Speaker Pelosi’s Drug Pricing Plan

Today House Speaker Nancy Pelosi released the drug pricing bill, H.R. 3 – The Lower Drug Costs Now Act. Congressman Waxman released this statement in support of the bill.

Waxman Strategies Publishes Series of Educational Drug Pricing Issue Briefs

The rising prices of prescription drugs are threatening the health and economic security of families across the country.

New Polling Shows Iowans Are Surprisingly Divided on the Renewable Fuel Standard

In the summer of 2019, a poll was conducted among likely voters and caucus-goers in the state of Iowa to learn more about the electorate’s understanding of and opinions about the Renewable Fuel Standard (RFS).

Waxman Strategies has compiled an explanatory memorandum to put these findings in context. Overall, the data shows that the RFS is weaker than it has been perceived over the last decade, failing to get majority support among Democrats and Independents. These voters also demonstrated an openness to new messaging, especially when that messaging spoke to the environmental impacts of policies supporting food-based biofuels.

Outcomes that Matter for the Planet: Waxman Strategies Celebrates Earth Day

At Waxman Strategies, our work is driven by a commitment to ensuring a livable, healthy planet. As we mark Earth Day we wanted to highlight some of the results our team and partners have achieved in our mission to be responsible stewards of this planet.

Waxman Strategies’ World Class Health Policy Team Continues Expansion

Two new specialists will focus on advancing healthcare system policy and legislation for the firm’s growing client base.